|Articles|September 16, 2013
Intelligent Statistical Monitoring Study Signals
A conversation with Marc Buyse, founder of CluePoints on risk based monitoring in clinical trials
Advertisement
A conversation with Marc Buyse, founder of CluePoints on risk based monitoring in clinical trials
This video is part of a series of conversations on
For more videos of Marc Buyse, see also:
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
2
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
3
CNS and Autoimmune Trials: Growth and Operational Implications
4
2025 Veeva R&D and Quality Summit: Effectively Utilizing Clinical Reference Data
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
